Effect of Meldonium on athletic performance is exaggerated
19 Aug 2016
Effect of a prohibited substance Meldonium (Mildronate) on sports performance athletes exaggerated WADA (WADA), says sports physician and consultant Anti-Doping Agency Estonia Sergei Ilyukov.
The winner of five Grand Slam tournaments Russian Maria Sharapova said it received notification that its doping sample taken during the performance at the Australian Open, Meldonium traces were found.
"Meldonium (Mildronate) is used as part of combination therapy in combination with other medicines for the treatment of coronary artery disease, but a dope it is in some way weak. Its influence on athletic performance exaggerated by the WADA, and it is forbidden on the basis of questionable evidence. It's sad, but the rules are there to ensure that their observe, "- said Ilyukov.
Meldonium was synthesized in 1975 in Riga. In Eastern Europe, the substance of the drug sold under the name of "Mildronate" which is a means of preventive treatment of a heart attack.